Literature DB >> 24998486

Involvement of TLR4 in oxidized LDL/β2GPI/anti-β2GPI-induced transformation of macrophages to foam cells.

Xiaolei Zhang1, Yachao Xie, Hong Zhou, Ya Xu, Jingjing Liu, Hongxiang Xie, Jinchuan Yan.   

Abstract

AIM: It has been reported that oxidized low-density lipoprotein (oxLDL) forms a stable and non-dissociable complex with β2-glycoprotein I (β2GPI) and that IgG anti-β2GPI autoantibodies are able to recognize this complex, thus facilitating macrophage-derived foam cell formation in patients with antiphospholipid syndrome (APS). However, the immunopathological mechanisms of oxLDL/β2GPI complexes in promoting foam cell formation are not fully understood. In this study, we examined the role of toll-like receptor 4 (TLR4) in the oxLDL/β2GPI/anti-β2GPI complex-induced transformation of mouse peritoneal macrophages to foam cells.
METHODS: Oil red O staining and optical density (OD) measurements of intracellular stained oil red O solution were used to monitor the transformation of peritoneal macrophages to foam cells in TLR4-competent C3H/HeN and TLR4-mutant C3H/HeJ mice. During foam cell formation induced by the oxLDL/β2GPI/anti-β2GPI complex, the expression of TLR4 and activation of nuclear factor kappa B (NF-κB) were confirmed by analyzing the protein and mRNA levels of these compounds. Furthermore, the related active molecule expression during foam cell formation induced by the oxLDL/β2GPI/anti-β2GPI complex was examined in the presence or absence of TLR4.
RESULTS: The data showed that treatment with the oxLDL/β2GPI/anti-β2GPI complex markedly increased foam cell formation, the TLR4 expression, NF-κB activation, the tissue factor (TF) expression and tumor necrosis factor-α (TNF-α) and monocyte chemotactic protein-1 (MCP-1) secretion in the C3H/HeN mice. However, the transformation of macrophages to foam cells and the expression levels of phosphorylated NF-κB, TF, TNF-α and MCP-1 were significantly reduced in the C3H/HeJ mice treated with the oxLDL/β2GPI/anti-β2GPI complex. In addition, compared with that achieved by oxLDL alone, the oxLDL/β2GPI complex decreased foam cell formation and the related signaling molecule expression in the C3H/HeN mice.
CONCLUSIONS: Our results indicate that TLR4 plays an important role in the process of oxLDL/β2GPI/anti-β2GPI complex-induced transformation of macrophages to foam cells, which may accelerate the development of atherosclerosis in the setting of APS. However, β2GPI alone functions as an antiatherogenic protein by preventing the foam cell formation induced by oxLDL.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24998486     DOI: 10.5551/jat.24372

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  14 in total

1.  Serum oxLDL-β2GPI complex reflects metabolic syndrome and inflammation in adipose tissue in obese.

Authors:  M Siklova; M Koc; L Rossmeislová; P Kraml
Journal:  Int J Obes (Lond)       Date:  2017-10-30       Impact factor: 5.095

2.  Adipose-derived mesenchymal stromal/stem cells in systemic sclerosis: Alterations in function and beneficial effect on lung fibrosis are regulated by caveolin-1.

Authors:  Rebecca Lee; Nicoletta Del Papa; Martin Introna; Charles F Reese; Marina Zemskova; Michael Bonner; Gustavo Carmen-Lopez; Kristi Helke; Stanley Hoffman; Elena Tourkina
Journal:  J Scleroderma Relat Disord       Date:  2019-01-25

Review 3.  Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention.

Authors:  Allison B Reiss; Benna Jacob; Saba Ahmed; Steven E Carsons; Joshua DeLeon
Journal:  Inflammation       Date:  2021-04-05       Impact factor: 4.092

4.  Oxidized Low-Density Lipoprotein Induces Apoptosis in Cultured Neonatal Rat Cardiomyocytes by Modulating the TLR4/NF-κB Pathway.

Authors:  Xiantao Wang; Yuhan Sun; Huafeng Yang; Yuanxi Lu; Lang Li
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

5.  Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies.

Authors:  Martina Fabris; Adriana Cifù; Cinzia Pistis; Massimo Siega-Ducaton; Desrè Ethel Fontana; Roberta Giacomello; Elio Tonutti; Francesco Curcio
Journal:  Auto Immun Highlights       Date:  2017-03-25

6.  Inhibition of epidermal growth factor receptor attenuates atherosclerosis via decreasing inflammation and oxidative stress.

Authors:  Lintao Wang; Zhouqing Huang; Weijian Huang; Xuemei Chen; Peiren Shan; Peng Zhong; Zia Khan; Jingying Wang; Qilu Fang; Guang Liang; Yi Wang
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

Review 7.  Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis.

Authors:  Joselyn Rojas; Juan Salazar; María Sofía Martínez; Jim Palmar; Jordan Bautista; Mervin Chávez-Castillo; Alexis Gómez; Valmore Bermúdez
Journal:  Scientifica (Cairo)       Date:  2015-09-27

8.  miR-223 Inhibits Lipid Deposition and Inflammation by Suppressing Toll-Like Receptor 4 Signaling in Macrophages.

Authors:  Jun Wang; Xiaojun Bai; Qiang Song; Fenling Fan; Zhi Hu; Gesheng Cheng; Yushun Zhang
Journal:  Int J Mol Sci       Date:  2015-10-20       Impact factor: 5.923

9.  Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect.

Authors:  Gerd Hörl; Harald Froehlich; Ulrika Ferstl; Gerhard Ledinski; Josepha Binder; Gerhard Cvirn; Tatjana Stojakovic; Michael Trauner; Christoph Koidl; Erwin Tafeit; Karin Amrein; Hubert Scharnagl; Günther Jürgens; Seth Hallström
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

10.  Dan-Lou Prescription Inhibits Foam Cell Formation Induced by ox-LDL via the TLR4/NF-κB and PPARγ Signaling Pathways.

Authors:  Li-Na Gao; Xin Zhou; Yu-Ren Lu; Kefeng Li; Shan Gao; Chun-Quan Yu; Yuan-Lu Cui
Journal:  Front Physiol       Date:  2018-05-29       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.